BeOne Medicines AG（ONC）價格預測ONCBeOne Medicines AG

Alphio's ONC stock price prediction model matches the current BeOne Medicines AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $381.52 (+1.03%). The 1-week path is $393.30 (+4.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Beigene, Ltd. (ONC) is a good buy right now due to its strong financial performance and positive catalysts. The current price is $377.63, with a gross margin of 89.76% in Q2 2026, indicating robust profitability. Additionally, analysts have set a price target range between $370 and $459, suggesting a potential upside of 10% to 22% from the current price. However, a significant risk is the hedge fund selling activity, which has increased by 7307.41% over the last quarter, indicating potential bearish sentiment among institutional investors.

BeOne Medicines AG (ONC) last closed at $377.63, losing -1.21%. These facts feed the 1-day and 1-week ONC price prediction above.